CAS 1400989-25-4

1-(4-Chloro-3-(Trifluoromethyl)Phenyl)-3-(3-(4-Cyanophenoxy)Phenyl)Urea

CAS : 1400989-25-4

Formule : C₂₁H₁₃ClF₃N₃O₂

Degré de pureté : 99%

Masse moléculaire : 431.7950

Ref: IN-DA01BRZJ

1-(4-Chloro-3-(Trifluoromethyl)Phenyl)-3-(3-(4-Cyanophenoxy)Phenyl)Urea

CAS : 1400989-25-4

1-(4-Chloro-3-(Trifluoromethyl)Phenyl)-3-(3-(4-Cyanophenoxy)Phenyl)Urea

Degré de pureté : 98%

Masse moléculaire : 431.8g/mol

Ref: 54-PC108739

SC-43

CAS : 1400989-25-4

SC-43

Degré de pureté : ≥98%

Masse moléculaire : 431.8g/mol

Ref: 54-BUP04224

SC-43

CAS : 1400989-25-4

SC-43 is a potent and orally active agonist of SHP-1 (PTPN6).

Formule : C₂₁H₁₃ClF₃N₃O₂

Degré de pureté : 98.44%

Couleur et forme : Solid

Masse moléculaire : 431.8

Ref: TM-T8478

1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea

CAS : 1400989-25-4

Tofacitinib is a drug that inhibits the activity of enzymes that are involved in the synthesis of collagen. It is used to treat fibrotic diseases, such as scleroderma, systemic sclerosis, and idiopathic pulmonary fibrosis. Tofacitinib has been shown to be effective in treating renal fibrosis, pancreatic fibrosis and cardiac fibrosis. Tofacitinib also reduces hepatic and hepatic fibrosis.

Formule : C₂₁H₁₃ClF₃N₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 431.8 g/mol

Ref: 3D-AGC98925